Initial influenza virus replication can be limited in allergic asthma through rapid induction of type III interferons in respiratory epithelium

Frontiers in Immunology

Volumn 9, Issue MAY, 2018, Pages

  An, Sujin ^a   Jeon, Yung Jin ^a,b   Jo, Ara ^a   Lim, Hyun Jung ^b   Han, Young Eun ^b   Cho, Sung Woo ^b   Kim, Hye Young ^a   Kim, Hyun Jik ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Acute viral lung infection; Asthma; Influenza A virus; Th2 cytokines; Type III interferon

Indexed keywords

INTERFERON; TYPE III INTERFERON; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT LOSS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INFLUENZA VIRUS; INNATE IMMUNITY; LUNG INFECTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; TH2 CELL; VIRUS LOAD; VIRUS REPLICATION;

EID: 85047093625     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00986     Document Type: Article

References (27)

1. Umetsu DT, DeKruyffRH. The regulation of allergy and asthma. Immunol Rev (2006) 212:238-55. doi:10.1111/j.0105-2896.2006.00413.x
2. Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev (2017) 278:162-72. doi:10.1111/imr.12557
3. Castillo JR, Peters SP, Busse WW. Asthma exacerbations: pathogenesis, prevention, and treatment. J Allergy Clin Immunol Pract (2017) 5:918-27. doi:10.1016/j.jaip.2017.05.001
4. Holt PG, Strickland DH. Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerba-tions. J Allergy Clin Immunol (2010) 125:963-72. doi:10.1016/j.jaci.2010.02.011
5. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in detente. Science (2006) 312:879-82. doi:10.1126/science.1125676
6. Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, et al. IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J (2013) 32:2751-63. doi:10.1038/emboj.2013.203
7. Galani IE, Triantafyllia V, Eleminiadou EE, Koltsida O, Stavropoulos A, Manioudaki M, et al. Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity (2017) 46:875-90. doi:10.1016/j.immuni.2017.04.025
8. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol (2010) 84:11515-22. doi:10.1128/JVI.01703-09
9. Kim BJ, Cho SW, Jeon YJ, An S, Jo A, Lim JH, et al. Intranasal delivery of Duox2 DNA using cationic polymer can prevent acute influenza A viral infection in vivo lung. Appl Microbiol Biotechnol (2018) 102:105-15. doi:10.1007/s00253-017-8512-1
10. Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy (2015) 70:910-20. doi:10.1111/all.12627
11. Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A (2008) 105:13562-7. doi:10.1073/pnas.0804181105
12. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med (2006) 12:1023-6. doi:10.1038/nm1462
13. Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, Ubel C, et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med (2011) 3:348-61. doi:10.1002/emmm.201100142
14. Ishikawa H, Sasaki H, Fukui T, Fujita K, Kutsukake E, Matsumoto T. Mice with asthma are more resistant to influenza virus infection and NK cells activated by the induction of asthma have potentially protective effects. J Clin Immunol (2012) 32:256-67. doi:10.1007/s10875-011-9619-2
15. Furuya Y, Furuya AK, Roberts S, Sanfilippo AM, Salmon SL, Metzger DW. Prevention of influenza virus-induced immunopathology by TGF-beta produced during allergic asthma. PLoS Pathog (2015) 11:e1005180. doi:10.1371/journal.ppat.1005180
16. Patel DA, You Y, Huang G, Byers DE, Kim HJ, Agapov E, et al. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J Allergy Clin Immunol (2014) 134:1402-12. doi:10.1016/j.jaci.2014.07.013
17. Kim S, Kim MJ, Kim CH, Kang JW, Shin HK, Kim DY, et al. The superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection. Am J Respir Cell Mol Biol (2017) 56:202-12. doi:10.1165/rcmb.2016-0174OC
18. Verhoeven D, Perry S, Pryharski K. Control of influenza infection is impaired by diminished interferon-γ secretion by CD4 T cells in the lungs of toddler mice. J Leukoc Biol (2016) 100:203-12. doi:10.1189/jlb.4A1014-497RR
19. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol (2004) 5:337-43. doi:10.1038/ni1041
20. Steinke JW, Borish L. Immune responses in rhinovirus-induced asthma exacerbations. Curr Allergy Asthma Rep (2016) 16:78. doi:10.1007/s11882-016-0661-2
21. Toussaint M, Jackson DJ, Swieboda D, Guedán A, Tsourouktsoglou TD, Ching YM, et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nat Med (2017) 23:681-91. doi:10.1038/nm.4332
22. Jarjour NN, Esnault S. Interleukin-33: a potential link between rhinovirus infections and asthma exacerbation. Am J Respir Crit Care Med (2014) 190:1336-7. doi:10.1164/rccm.201411-1949ED
23. Johnston SL. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc Am Thorac Soc (2007) 4:267-70. doi:10.1513/pats.200701-030AW
24. Tworek D, Heroux D, O'Byrne SN, Mitchell P, O'Byrne PM, Denburg JA. Toll-like receptor-induced expression of epithelial cytokine receptors on haemopoietic progenitors is altered in allergic asthma. Clin Exp Allergy (2017) 47:900-8. doi:10.1111/cea.12913
25. Riese RJ, Finn PW, Shapiro SD. Influenza and asthma: adding to the respiratory burden. Nat Immunol (2004) 5:243-4. doi:10.1038/ni0304-243
26. Sykes A, Edwards MR, Macintyre J, del Rosario A, Bakhsoliani E, Trujillo-Torralbo MB, et al. Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol (2012) 29:1506-14. doi:10.1016/j.jaci.2012.03.044
27. Hong SN, Kim JY, Kim H, Kim DY, Won TB, Han DH, et al. Duox2 is required for the transcription of pattern recognition receptors in acute viral lung infection: an interferon-independent regulatory mechanism. Antiviral Res (2016) 134:1-5. doi:10.1016/j.antiviral.2016.08.017